BOSTON, Sept. 21 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company will be holding its annual shareholder meeting on Tuesday, September 28, 2010 at 9:00am EDT. The meeting will be held at the Hilton of Boston/Dedham located at 25 Allied Drive, Dedham, MA 02026. The agenda for the 2010 shareholder's meeting include proposals to re-elect the current Board of Directors and approve the appointment of Fred Schiemann, CPA, as the Company's accountant.
Proxy statements describing the proposals on the agenda and proxy cards for use by shareholders that cannot attend the meeting in person were sent by mail, on or about September 14, 2010, to the Company's shareholders of record as of August 27, 2010 and to shareholders that hold shares registered with Pacific Stock Transfer Company.
The Company has posted its financial results for the first six months ended June 30, 2010 on Pink Sheets OTC Markets website (http://www.otcmarkets.com/pink/quote/quote.jsp?symbol=sndy).
About Solos Endoscopy, Inc.:
Solos Endoscopy, Inc. is a HealthCare instrument company whose mission is to develop and market high quality and innovative instruments for the screening, diagnosis, treatment and management of medical conditions. Additional information on its FDA approved products is available on the Company's website at: www.solosendoscopy.com.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
|SOURCE Solos Endoscopy, Inc.|
Copyright©2010 PR Newswire.
All rights reserved